Merck & Co Inc (MRK)
126.88
-0.06
(-0.05%)
USD |
NYSE |
Apr 23, 16:00
126.85
-0.03
(-0.02%)
After-Hours: 20:00
Merck Price to Book Value: 8.551 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 8.555 |
| April 19, 2024 | 8.476 |
| April 18, 2024 | 8.440 |
| April 17, 2024 | 8.449 |
| April 16, 2024 | 8.428 |
| April 15, 2024 | 8.504 |
| April 12, 2024 | 8.474 |
| April 11, 2024 | 8.502 |
| April 10, 2024 | 8.542 |
| April 09, 2024 | 8.539 |
| April 08, 2024 | 8.529 |
| April 05, 2024 | 8.626 |
| April 04, 2024 | 8.603 |
| April 03, 2024 | 8.754 |
| April 02, 2024 | 8.784 |
| April 01, 2024 | 8.828 |
| March 28, 2024 | 8.892 |
| March 27, 2024 | 8.879 |
| March 26, 2024 | 8.459 |
| March 25, 2024 | 8.445 |
| March 22, 2024 | 8.346 |
| March 21, 2024 | 8.331 |
| March 20, 2024 | 8.346 |
| March 19, 2024 | 8.235 |
| March 18, 2024 | 8.184 |
| Date | Value |
|---|---|
| March 15, 2024 | 8.189 |
| March 14, 2024 | 8.121 |
| March 13, 2024 | 8.233 |
| March 12, 2024 | 8.266 |
| March 11, 2024 | 8.274 |
| March 08, 2024 | 8.323 |
| March 07, 2024 | 8.356 |
| March 06, 2024 | 8.340 |
| March 05, 2024 | 8.278 |
| March 04, 2024 | 8.360 |
| March 01, 2024 | 8.556 |
| February 29, 2024 | 8.569 |
| February 28, 2024 | 8.639 |
| February 27, 2024 | 8.696 |
| February 26, 2024 | 8.683 |
| February 23, 2024 | 8.724 |
| February 22, 2024 | 8.711 |
| February 21, 2024 | 8.634 |
| February 20, 2024 | 8.584 |
| February 16, 2024 | 8.612 |
| February 15, 2024 | 8.528 |
| February 14, 2024 | 8.479 |
| February 13, 2024 | 8.453 |
| February 12, 2024 | 8.447 |
| February 09, 2024 | 8.454 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.866
Minimum
Feb 24 2022
8.892
Maximum
Mar 28 2024
6.641
Average
6.714
Median
Oct 05 2020
Price to Book Value Benchmarks
| Amgen Inc | 23.53 |
| Johnson & Johnson | 5.241 |
| Eli Lilly and Co | 65.77 |
| Pfizer Inc | 1.670 |
| Moderna Inc | 2.979 |
Price to Book Value Related Metrics
| PE Ratio | 906.36 |
| PS Ratio | 5.370 |
| Price to Free Cash Flow | 35.31 |
| Price | 126.88 |
| Earnings Yield | 0.11% |
| Market Cap | 321.37B |
| Operating PE Ratio | 109.33 |
| Normalized PE Ratio | 397.95 |